Multiple sclerosis (MS) exhibits a notable seasonal pattern in both clinical expression and underlying pathophysiology. The interplay between environmental factors and immune regulation underpins ...

More research is necessary to understand cerebral oxygen consumption as a predictive biomarker for brain atrophy in multiple sclerosis (MS); however, this study found that mitochondrial dysfunction ...

Synaptic injury in the IPL of the retina is linked to MS progression, with IPL thickness as a potential biomarker. Hypoxia in MS patients exacerbates inflammation and mitochondrial damage, ...

Multiple sclerosis is an autoimmune condition that affects the nervous system, leading to nerve damage and chronic inflammation. While the exact cause of this disorder is unknown, experts believe ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders through chronic inflammation. However, its role in multiple sclerosis, a ...

The Marburg variant of multiple sclerosis is extremely rare but also the most severe. Life expectancy has been weeks or months, but advances in treatment have led to an improved outlook. Multiple ...

Multiple sclerosis (MS) affects the protective myelin sheath around nerve fibers in the brain and spinal cord, while muscular dystrophy (MD) is a group of genetic conditions that damage and destroy ...

Multiple sclerosis, or MS, is a disease of the central nervous system that can cause symptoms throughout the body. The term “multiple sclerosis” refers to the multiple areas of scar tissue — often ...

Multiple sclerosis (MS) and transverse myelitis are conditions that affect the central nervous system (CNS). However, MS affects nerves in the brain and spinal cord, while transverse myelitis only ...